SRPK1 and cancer: And skipping exon 3 could generate the soluble PD-1, which was naturally produced in peripheral blood mononuclear cells and T cells, preventing cancer cells from suppressing T cell activity, which was regulated by SRSF1 and SR protein kinase 1 (SRPK1) (62).